Venous thromboembolism following microsurgical breast reconstruction: An objective analysis in 225 consecutive patients using low-molecular-weight heparin prophylaxis

Plastic and Reconstructive Surgery

Volumn 127, Issue 4, 2011, Pages 1399-1406

  Lemaine, Valerie ^a   McCarthy, Colleen ^a   Kaplan, Karly ^a   Mehrara, Babak ^a   Pusic, Andrea L ^a   Cordeiro, Peter G ^a   Disa, Joseph J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ARTICLE; BREAST RECONSTRUCTION; BREAST TUMOR; DOPPLER ECHOGRAPHY; ECHOGRAPHY; FEMALE; FREE TISSUE GRAFT; HUMAN; LEG; MASTECTOMY; MIDDLE AGED; POSTOPERATIVE COMPLICATION; VASCULARIZATION; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

ADULT; AGED; ANTICOAGULANTS; BREAST NEOPLASMS; FEMALE; FREE TISSUE FLAPS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; LEG; MAMMAPLASTY; MASTECTOMY; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; ULTRASONOGRAPHY, DOPPLER, DUPLEX; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 79955046295     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e318208d025     Document Type: Article

References (36)

1. Zhan C, Miller MR. Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization. JAMA. 2003;290:1868-1874. (Pubitemid 37430603)
2. Broughton G 2nd, Rios JL, Rohrich RJ, et al. Deep venous thrombosis prophylaxis practice and treatment strategies among plastic surgeons: survey results. Plast Reconstr Surg. 2007;119:157-174. (Pubitemid 46360260)
3. Kim EK, Eom JS, Ahn SH, et al. The efficacy of prophylactic low-molecular-weight heparin to prevent pulmonary thromboembolism in immediate breast reconstruction using the TRAM flap. Plast Reconstr Surg. 2009;123:9-12.
4. Liao EC, Taghinia AH, Nguyen LP, et al. Incidence of hematoma complication with heparin venous thrombosis prophylaxis after TRAM flap breast reconstruction. Plast Reconstr Surg. 2008;121:1101-1107. (Pubitemid 351653204)
5. Spear SL, Ducic I, Low M, et al. The effect of radiation on pedicled TRAM flap breast reconstruction: outcomes and implications. Plast Reconstr Surg. 2005;115:84-95. (Pubitemid 40187801)
6. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, 8th ed. Chest 133:381S-453S, 2008. (Pubitemid 351894916)
7. Caprini JA. Thrombosis risk assessment as a guide to quality patient care. Dis Mon. 2005;51:70-78. (Pubitemid 40719347)
8. Caprini JA. Risk assessment as a guide for the prevention of the many facesofvenous thromboembolism. Am J Surg. 2010;199: S3-S10.
9. Caprini JA. Venous thromboembolism in surgery: A preventable complication-Introduction. Am J Surg.; 199: S1-S2.
10. Bahl V, Hu HM, Henke PK, et al. A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg. 2010;251:344-350.
11. Davison SP, Venturi ML, Attinger CE, et al. Prevention of venous thromboembolism in the plastic surgery patient. Plast Reconstr Surg. 2004;114:43E-51E.
12. Hatef DA, Kenkel JM, Nguyen MQ, et al. Thromboembolic risk assessment and the efficacy of enoxaparin prophylaxis in excisional body contouring surgery. Plast Reconstr Surg. 2008;122:269-279.
13. Cronan JJ. Ultrasound evaluation of deep venous thrombosis. Semin Roentgenol. 1992;27:39-52.
14. Cook D, Meade M, Guyatt G, et al. Clinically important deep vein thrombosis in the intensive care unit: A survey of intensivists. Crit Care 2004;8: R145-152.
15. Harrison L, McGinnis J, Crowther M, et al. Assessment of outpatient treatment of deep-vein thrombosis with lowmolecular-weight heparin. Arch Intern Med. 1998;158:2001-2003. (Pubitemid 28465624)
16. Hirsh J, Anand SS, Halperin JL, et al. AHA Scientific Statement. Guide to anticoagulant therapy: Heparin-A statement for healthcare professionals from the American Heart Association. Arterioscler Thromb Vasc Biol. 2001;21: E9-E9.
17. Hirsh J, Warkentin TE, Shaughnessy SG, et al. Heparin and low-molecular-weight heparin: Mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 2001;119:64S-94S. (Pubitemid 32154195)
18. Lee AY. Epidemiology and management of venous thromboembolism in patients with cancer. Thromb Res. 2003;110:167-172. (Pubitemid 37338288)
19. Lee AY. The role of low-molecular-weight heparins in the prevention and treatment of venous thromboembolism in cancer patients. Curr Opin Pulm Med. 2003;9:351-355. (Pubitemid 36994060)
20. Lee AY, Levine MN. Venous thromboembolism and cancer: Risks and outcomes. Circulation 2003;107: I17-I21. (Pubitemid 41289267)
21. Osborne NH, Wakefield TW, Henke PK. Venous thromboembolism in cancer patients undergoing major surgery. Ann Surg Oncol. 2008;15:3567-3578.
22. Rembold CM. Number needed to screen: Development of a statistic for disease screening. BMJ. 1998;317:307-312. (Pubitemid 28353824)
23. Sullivan SR, Fletcher DR, Isom CD, et al. True incidence of all complications following immediate and delayed breast reconstruction. Plast Reconstr Surg. 2008;122:19-28.
24. Leonardi MJ, McGory ML, Ko CY. The rate of bleeding complications after pharmacologic deep venous thrombosis prophylaxis:Asystematic review of 33r and omized controlled trials. Arch Surg. 2006;141:790-797; discussion 797-799. (Pubitemid 44268523)
25. Lohr JM, James KV, Deshmukh RM, et al. Allastair B. Karmody Award: Calf vein thrombi are not a benign finding. Am J Surg. 1995;170:86-90.
26. Masuda EM, Kessler DM, Kistner RL. The natural history of calf vein thrombosis: Lysis of thrombi and development of reflux. J Vasc Surg. 1998;28:67-73; discussion 73-74.
27. Schulman S, Granqvist S, Juhlin-Dannfelt A, et al. Long-term sequelae of calf vein thrombosis treated with heparin or low-dose streptokinase. Acta Med Scand. 1986;219:349-357. (Pubitemid 16052284)
28. Giannoukas AD, Labropoulos N, Burke P, et al. Calf deep venous thrombosis: a review of the literature. Eur J Vasc Endovasc Surg. 1995;10:398-404.
29. Haas SB, Tribus CB, Insall JN, et al. The significance of calf thrombi after total knee arthroplasty. J Bone Joint Surg Br. 1992;74:799-802.
30. Deitcher SR, Caprini JA. Calf deep venous thrombosis should be treated with anticoagulation. Med Clin North Am. 2003;87:1157-1164. (Pubitemid 37485290)
31. Rotert EM, Basarich JR, Nashelsky J. Treatment of calf deep venous thrombosis. Am Fam Physician 2005;71:2157-2158. (Pubitemid 40799811)
32. Solis MM, Ranval TJ, Nix ML. Isanticoagulation indicated for asymptomatic postoperative calf vein thrombosis? J Vasc Surg. 1992;16:414-418; discussion 418-419.
33. Moser KM, LeMoine JR. Is embolic risk conditioned by location of deep venous thrombosis? Ann Intern Med. 1981;94:439-444. (Pubitemid 11103939)
34. Schellong SM, Beyer J, Kakkar AK, et al. Ultrasound screening for asymptomatic deep vein thrombosis after major orthopaedic surgery: The VENUS study. J Thromb Haemost. 2007;5:1431-1437. (Pubitemid 46965371)
35. Oger E, Bressollette L, Nonent M, et al. High prevalence of asymptomatic deep vein thrombosis on admission in a medical unit among elderly patients. Thromb Haemost. 2002;88:592-597. (Pubitemid 35174000)
36. Tomkowski WZ, Davidson BL, Wisniewska J, et al. Accuracy of compression ultrasound in screening for deep venous thrombosis in acutely ill medical patients. Thromb Haemost. 2007;97:191-194. (Pubitemid 46592138)